Related Experiment Video
Updated: Jun 16, 2026
07:24
Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
Published on: May 25, 2022
Newcastle disease virus as an oncolytic agent
P V Ravindra1, Ashok K Tiwari, Bhaskar Sharma
1Molecular Biology Laboratory, Division of Animal Biotechnology, Indian Veterinary Research Institute, Izatnagar, India. raviravindra1@gmail.com
The Indian Journal of Medical Research
|January 22, 2010
Summary
Newcastle disease virus (NDV) shows promise as an oncolytic virotherapy for cancer treatment. This virus selectively targets and destroys tumor cells while stimulating the immune system, offering a potential alternative to conventional therapies.
Area of Science:
- Oncology
- Virology
- Immunotherapy
Background:
- Cancer remains a leading cause of human mortality, with current treatments like chemotherapy and radiotherapy exhibiting limitations in efficacy and significant toxicities.
- The need for novel therapeutic strategies has driven research into alternative approaches, including oncolytic virotherapy.
- Newcastle disease virus (NDV), a virus primarily known for causing disease in poultry, possesses inherent oncolytic and immunostimulatory properties beneficial for human cancer treatment.
Purpose of the Study:
- To investigate the potential of Newcastle disease virus (NDV) as an oncolytic agent for cancer therapy.
- To explore the selective replication of NDV in tumor cells and its impact on normal cells.
- To highlight the advancements in recombinant NDV development for enhanced therapeutic efficacy.
Main Methods:
- Review of existing research on Newcastle disease virus (NDV) strains and their application in cancer treatment.
- Examination of NDV's mechanism of action, including selective tumor cell replication and oncolysis.
- Consideration of recent progress in reverse genetics for engineering recombinant NDV with improved oncolytic capabilities.
Main Results:
- NDV demonstrates selective replication within tumor cells, leading to oncolysis while sparing healthy tissues.
- NDV exhibits immunostimulatory effects, potentially enhancing the body's anti-cancer immune response.
- Recombinant NDV technologies offer the potential to optimize the virus's oncolytic potency and therapeutic application.
Conclusions:
- Newcastle disease virus (NDV) presents a promising candidate for oncolytic virotherapy due to its selective tumor-killing ability and immune-stimulating properties.
- Further research and development, particularly using recombinant NDV, are warranted to fully harness its therapeutic potential against various human cancers.
- Oncolytic virotherapy using NDV offers a potential alternative or complementary strategy to conventional cancer treatments.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...